Oncology & Cancer

The behavior of therapeutic antibodies in immunotherapy

Since the late 1990s, immunotherapy has been the frontline treatment against lymphomas where synthetic antibodies are used to stop the proliferation of cancerous white blood cells. However, in the more than 20 years since ...

Oncology & Cancer

Internal differences: A new method for seeing into cells

Invading cells' private space—prying into their internal functions, decisions and communications—could be a powerful tool that may help researchers develop new immunotherapy treatment for cancer. As reported today in ...

Diseases, Conditions, Syndromes

Study reveals immune-system paralysis in severe COVID-19 cases

A Stanford study shows that in severely ill COVID-19 patients, "first-responder" immune cells, which should react immediately to signs of viruses or bacteria in the body, instead respond sluggishly.

Oncology & Cancer

Immunotherapy-resistant cancers eliminated in mouse study

Immunotherapy has revolutionized cancer treatment by stimulating the patient's own immune system to attack cancer cells, yielding remarkably quick and complete remission in some cases. But such drugs work for less than a ...

Diseases, Conditions, Syndromes

Malaria discovery could expedite antiviral treatment for COVID-19

The study, conducted by an international team and led by RMIT University's Professor Christian Doerig, outlines a strategy that could save years of drug discovery research and millions of dollars in drug development by repurposing ...

page 1 from 2